(VIANEWS) – NYSE Composite ended the session with Novo Nordisk A/S jumping 5.47% to $98.21 on Wednesday, following the last session’s upward trend. NYSE Composite dropped 0.5% to $16,629.50, following the last session’s upward trend on what was a somewhat down trend exchanging session today.
Today’s last reported volume for Novo Nordisk A/S is 3110340, 237.55% above its average volume of 921434.
Novo Nordisk A/S’s last close was $92.60, 0.46% higher than its 52-week high of $92.18.
Novo Nordisk A/S’s Sales
Novo Nordisk A/S’s sales growth is 8.1% for the current quarter and 7.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 6.9% and 5.6%, respectively.
Novo Nordisk A/S’s Revenue
Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 126.88B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Novo Nordisk A/S’s stock is considered to be oversold (<=20).
Novo Nordisk A/S’s Stock Yearly Top and Bottom Value
Novo Nordisk A/S’s stock is valued at $98.21 at 17:18 EST, above its 52-week high of $92.18.
Novo Nordisk A/S’s Moving Average
Novo Nordisk A/S’s worth is way higher than its 50-day moving average of $85.13 and way higher than its 200-day moving average of $76.14.
More news about Novo Nordisk A/S (NVO).